Tandem Diabetes Care Inc 8-K Filing
Ticker: TNDM · Form: 8-K · Filed: Nov 12, 2025 · CIK: 1438133
| Field | Detail |
|---|---|
| Company | Tandem Diabetes Care Inc (TNDM) |
| Form Type | 8-K |
| Filed Date | Nov 12, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $300,000, $60,000, $11,000, $6,000 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Tandem Diabetes Care Inc (ticker: TNDM) to the SEC on Nov 12, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ich Registered Common Stock, par value $0.001 per share TNDM NASDAQ Global Market I); $300,000 (y's common stock, reflecting a value of $300,000, as calculated in accordance with the t); $60,000 (igible to receive an annual retainer of $60,000 for her service on the Board, additiona); $11,000 (e Board, additional annual retainers of $11,000 for her service on the Audit Committee); $6,000 (her service on the Audit Committee and $6,000 for her service on the C/D/P Committee,).
How long is this filing?
Tandem Diabetes Care Inc's 8-K filing is 2 pages with approximately 725 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 725 words · 3 min read · ~2 pages · Grade level 11 · Accepted 2025-11-12 09:02:09
Key Financial Figures
- $0.001 — ich Registered Common Stock, par value $0.001 per share TNDM NASDAQ Global Market I
- $300,000 — y's common stock, reflecting a value of $300,000, as calculated in accordance with the t
- $60,000 — igible to receive an annual retainer of $60,000 for her service on the Board, additiona
- $11,000 — e Board, additional annual retainers of $11,000 for her service on the Audit Committee
- $6,000 — her service on the Audit Committee and $6,000 for her service on the C/D/P Committee,
- $180,000 — ith an aggregate value of approximately $180,000, as calculated in accordance with the t
Filing Documents
- tndm-20251107.htm (8-K) — 26KB
- exhibit991-pressreleasexbo.htm (EX-99.1) — 7KB
- tandemhorizontallogonewrgb.jpg (GRAPHIC) — 63KB
- 0001438133-25-000190.txt ( ) — 231KB
- tndm-20251107.xsd (EX-101.SCH) — 2KB
- tndm-20251107_lab.xml (EX-101.LAB) — 21KB
- tndm-20251107_pre.xml (EX-101.PRE) — 12KB
- tndm-20251107_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Number Description 99.1 Press release of Tandem Diabetes Care, Inc. dated November 12, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Tandem Diabetes Care, Inc. By: /s/ SHANNON M. HANSEN Shannon M. Hansen Executive Vice President, Chief Legal, Privacy & Compliance Officer and Secretary Date: November 12, 2025 3